| scientific journal | Q5633421 |
| P495 | country of origin | United States of America | Q30 |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| P407 | language of work or name | English | Q1860 |
| P1476 | title | Bulletin on the rheumatic diseases |
| Q78419598 | 1958 Revision of diagnostic criteria for rheumatoid arthritis |
| Q40252963 | A brief history of the rheumatic diseases. |
| Q73613856 | A hemagglutination test for rheumatoid arthritis with enhanced sensitivity using the euglobulin fraction |
| Q67457451 | A view on the pathogenesis of osteoarthritis |
| Q37043086 | AIDS and Sjogren's syndrome |
| Q38005115 | AIDS and the rheumatic diseases. |
| Q40748450 | ANAs and antibodies to DNA: their use in clinical diagnosis |
| Q35632115 | ANCA--diagnostic markers or pathogenic agents? |
| Q67974934 | ANCA--the rheumatologist's perspective 1992 |
| Q72367132 | Acute arthritis |
| Q73871726 | Acute monarthritis |
| Q79101247 | Acute suppurative arthritis |
| Q73335992 | Addressing work disability through vocational rehabilitation services |
| Q75984577 | Adrenal function in rheumatoid arthritis |
| Q73253985 | Adult-onset Still's disease |
| Q69933460 | Advances in rheumatology: 1934-1984 |
| Q39858864 | Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy) |
| Q77930361 | Aggressive treatment of early rheumatoid arthritis to prevent joint damage |
| Q77060992 | Alcaptonuria and ochronotic arthritis |
| Q73255058 | Alternative treatments and rheumatic diseases |
| Q73682368 | American Rheumatism Association interim session at Bethesda |
| Q66902463 | Amyloidosis |
| Q70211803 | Amyloidosis |
| Q71860352 | An appraisal of indomethacin |
| Q34714973 | An update on specific COX-2 inhibitors: the COXIBs |
| Q71979509 | Another look at minocycline |
| Q45094756 | Anterior knee pain--a symptom not a diagnosis |
| Q40748459 | Antibodies to defined antigens in the systemic rheumatic diseases |
| Q74801176 | Antimalarial compounds in rheumatoid arthritis |
| Q77522553 | Antineutrophil cytoplasmic antibodies |
| Q78768904 | Antinuclear antibodies and their detection in systemic lupus erythematosus (SLE) |
| Q69879396 | Antinuclear antibodies in the investigation of rheumatic diseases |
| Q41432113 | Antirheumatic drug therapy during pregnancy. |
| Q40826565 | Apheresis and the rheumatic diseases |
| Q46374497 | Apoptosis in rheumatic disease |
| Q71760453 | Approach to the patient with myopathy |
| Q33873612 | Approach to the patient with suspected vasculitis. |
| Q78467379 | Approaches to the study of connective tissue |
| Q72398721 | Arm pain in the work place |
| Q74475578 | Arthritis and hepatitis |
| Q40029740 | Arthritis associated with hematologic disorders |
| Q68002903 | Arthritis in the elderly |
| Q37713555 | Arthritis of the foot |
| Q66890845 | Arthritis of the temporomandibular joints and facial pain |
| Q67974927 | Arthritis patient education |
| Q70668494 | Arthroscopy and arthroscopic surgery |
| Q44712341 | Aspirin in rheumatoid arthritis, a seven-day, double-blind trial--preliminary report |
| Q46482260 | Athletic amenorrhea and its influence on skeletal integrity. |
| Q71713867 | Autoantibodies in systemic sclerosis |
| Q40703847 | Behavioral interventions for managing chronic pain |
| Q67376043 | Behçet's syndrome |
| Q41503086 | Benefits of low-dose corticosteroids in rheumatoid arthritis. |
| Q74244520 | Biopsy as a diagnostic procedure in rheumatic diseases |
| Q73290468 | Blood and nerve supply of joints |
| Q73225988 | Boy with peripheral joint pain |
| Q40525193 | CPPDDD: what is it and why is it underrecognized? |
| Q73354091 | Calcified deposits in the subdeltoid bursa |
| Q71452357 | Career counseling for teenagers with arthritis |
| Q71915459 | Case management study: Raynaud's phenomenon |
| Q73101806 | Case management study: an elderly patient with muscle pain |
| Q44671379 | Case management study: boy with peripheral joint pain |
| Q30468600 | Case management study: heel pain in the adult. |
| Q73965180 | Case management study: methotrexate side effects--or not? |
| Q71722303 | Case management study: osteoarthritis of the knee |
| Q71601443 | Case management study: osteoporotic fracture |
| Q74334511 | Case management study: osteoporotic vertebral compression fracture |
| Q74574468 | Case management study: polyarthritis with fever |
| Q41338509 | Cementless joint replacement: current status and future |
| Q70742965 | Certification in sports medicine--improving the quality of care for all athletes |
| Q40000192 | Cervical and lumbar disc disease: a review |
| Q39811724 | Chemistry and biosynthesis of collagen |
| Q71421488 | Chondromalacia of the patella |
| Q73871739 | Chondroprotection in osteoarthritis |
| Q44161393 | Chronic BFP reactors and their relation to DGG, CVD, and SLE. |
| Q67535567 | Chrysotherapy |
| Q75984566 | Clinical and metabolic effects of benemid in gout |
| Q39953415 | Clinical significance of monoclonal immunoglobulinemia |
| Q71298859 | Colchicine: current problems |
| Q68856295 | Collagens and human disease |
| Q73475530 | Common painful foot syndromes |
| Q66849970 | Control of purine biosynthesis in normal and pathologic states |
| Q40205215 | Controversial arthritis remedies. |
| Q78976539 | Corticosteroid therapy in lupus nephritis. Importance of adequate dosage |
| Q73582491 | Cortisone therapy in rheumatoid arthritis: a four-year appraisal |
| Q73803885 | Cost effective use of laboratory tests in rheumatology |
| Q69239601 | Criteria for the classification of juvenile rheumatoid arthritis |
| Q72351347 | Current concepts of degenerative joint disease (osteoarthritis) |
| Q40986674 | Current evaluation of the diagnosis, treatment and prevention of rheumatic fever |
| Q74415450 | Current status of gold compounds in the treatment of rheumatoid arthritis |
| Q40922065 | Cyclosporine in the treatment of rheumatoid arthritis |
| Q43600602 | D-penicillamine. |
| Q40215905 | DRG legislation and rheumatic disease |
| Q41503077 | Dangers of low-dose corticosteroid therapy in rheumatoid arthritis |
| Q45111888 | Diagnosis and management of complicated gout. |
| Q79182063 | Diagnosis of amyloidosis |
| Q33971146 | Diagnostic criteria for population studies |
| Q75534479 | Differential diagnosis of the major types of arthritic disease |
| Q39841169 | Disorders of collagen structure and metabolism |
| Q40885354 | Disorders of the axial skeleton which are lesser known, poorly recognized or misunderstood |
| Q67649991 | Do gold shots really work for rheumatoid arthritis? |
| Q71996450 | Doing no harm: rethinking an old standard in a new era |
| Q36186921 | Drug therapy of rheumatic diseases during pregnancy |
| Q67857445 | Drug-related lupus |
| Q35569783 | Early mortality in RA predicted by poor clinical status |
| Q72704269 | Economic evaluation of arthritis patient education |
| Q43762857 | Education in rheumatology |
| Q79348724 | Evaluation of the status of patients with rheumatoid arthritis after five or more years of corticosteroid treatment |
| Q74382252 | Examination of synovial fluid |
| Q72799320 | Examination of the patient with low back pain |
| Q38037590 | Exercise and arthritis |
| Q67958765 | Exercise and osteoarthritis |
| Q40781046 | Exercise strategies for osteoporosis |
| Q39858271 | Experimental models of osteoarthritis |
| Q79618954 | Experimental studies of degenerative joint disease |
| Q40208897 | Extraarticular manifestations of rheumatoid arthritis |
| Q40174488 | Extrahepatic manifestations of hepatitis B infection |
| Q72587101 | Fatigue in rheumatic disease |
| Q71452353 | Fibromyalgia syndrome: approaches to management |
| Q37938496 | Fibrositis/fibromyalgia: a difference of opinion |
| Q73594315 | Foot and ankle issues in rheumatoid arthritis |
| Q72449891 | Frozen shoulder |
| Q40748447 | Future care of rheumatoid arthritis in a managed care environment. |
| Q41134653 | General considerations for managing tendon injuries. |
| Q35569773 | Genetics and osteoarthritis |
| Q73839879 | Genetics and rheumatic diseases: rheumatoid arthritis and ankylosing spondylitis. The genetics of rheumatoid arthritis |
| Q34974450 | Getting to the heart of the matter in systemic lupus and rheumatoid arthritis. |
| Q67402489 | Giant cell arteritis: a review |
| Q71431822 | Giant cell arteritis: diagnosis and management |
| Q43724733 | Glucosamine and chondroitin for osteoarthritis? |
| Q78924959 | Gold therapy in rheumatoid arthritis. A multi-centre controlled trial conducted by the Research Sub-Committee of the Empire Rheumatism Council |
| Q74334515 | Gonococcal arthritis |
| Q34714969 | Gout basics. |
| Q72097023 | Guidelines for rheumatic disease management |
| Q40703853 | HIV infection and rheumatic disease. |
| Q72105043 | HLA-DRB1 alleles as severity markers in RA |
| Q72094337 | Health services research in rheumatology |
| Q68182161 | Heat shock proteins and arthritis |
| Q57674513 | Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime? |
| Q74603994 | Hemophilic arthritis |
| Q94290498 | Herniation of the lumbar intervertebral disc |
| Q73847407 | Hormone treatment of rheumatic carditis |
| Q45758892 | Human immunodeficiency virus infection and rheumatic disease |
| Q77633504 | Hyaluronic acid treatment (viscosupplementation) for OA of the knee |
| Q41932121 | Hydroxychloroquine therapy in rheumatic diseases |
| Q74487260 | Hypertrophic osteoarthropathy |
| Q40060408 | Hypoxanthine-guanine phosphoribosyltransferase deficiency |
| Q76939864 | INFLUENCE OF GENETIC AND ENVIRONMENTAL FACTORS ON THE OCCURENCE OF RHEUMATOID ARTHRITIS AND RHEUMATOID FACTOR IN AMERICAN INDIANS |
| Q73101802 | Illness behavior and the biomedical model |
| Q40467881 | Immune mechanisms in the pathogenesis of systemic lupus erythematosus. |
| Q40010141 | Immunologic deficiency diseases |
| Q72115558 | Immunologic studies in juvenile arthritis |
| Q40640063 | Immunologic tests in the diagnosis of rheumatic diseases |
| Q39421678 | Immunologic tests in the diagnosis of rheumatic diseases. Part I. |
| Q68445026 | Immunopathologic mechanisms. I. Allergic phenomena mediated by antibody |
| Q71229900 | Immunopathologic mechanisms. II. Allergic phenomena mediated by cells |
| Q46128946 | Impact of the American Health Security Act of 1993. |
| Q37929958 | Infection and rheumatic diseases: a review (2). |
| Q38778595 | Infection and rheumatic diseases: a review (Part 1 of 2). |
| Q67958762 | Influencing mortality outcomes in RA |
| Q39738518 | Interactions involving antirheumatic agents. Part I |
| Q40679175 | Interactions involving antirheumatic agents. Part II |
| Q68816611 | Interpreting clinical trials of antirheumatic drug therapy |
| Q78885375 | Intra-synovial corticosteroid therapy: a decade of use |
| Q40548891 | Intravenous immunoglobulin therapy |
| Q72398723 | Is seronegative RA in the elderly the same as polymyalgia rheumatica? |
| Q72612147 | Is there a role for diet or other questionable therapies in managing rheumatic diseases? |
| Q52255172 | It is lupus? |
| Q76044646 | Joint involvement in lupus erythematosus disseminatus |
| Q78318678 | Joint lubrication |
| Q74641644 | Joint replacement surgery: preoperative management |
| Q40578766 | Knee meniscal transplantation |
| Q73338996 | Leflunomide for the treatment of rheumatoid arthritis |
| Q41278835 | Legal rights of children with musculoskeletal disabilities. |
| Q40826557 | Life after total hip arthroplasty. |
| Q75672438 | Local and regional analgesic injections in painful musculoskeletal conditions |
| Q68146387 | Lung involvement in systemic sclerosis |
| Q40525187 | Lupus and pregnancy. |
| Q73360838 | Lupus for the non-rheumatologist |
| Q40665997 | Lupus in New Zealand mice and in dogs |
| Q41838533 | Lyme antibodies and Lyme disease: when to measure and who to treat |
| Q78034072 | Lyme disease and the Lyme disease vaccines |
| Q40657205 | Lyme disease--1993. |
| Q39953420 | Lymphocyte biology. Part I |
| Q39953425 | Lymphocyte biology. Part II. |
| Q78363732 | MEDICAL MANAGEMENT OF JUVENILE RHEUMATOID ARTHRITIS |
| Q40407599 | MRS and NIRS for muscle disease evaluation. |
| Q68680712 | Magnetic resonance imaging in musculoskeletal disorders |
| Q69837779 | Management and prognosis of systemic lupus erythematosus |
| Q40035197 | Management of ankylosing spondylitis |
| Q40256344 | Management of ankylosing spondylitis. |
| Q72105040 | Management of avascular necrosis of the femoral head |
| Q75589070 | Management of gouty arthritis |
| Q71490910 | Management of osteoarthritis |
| Q41432120 | Management of skin disease in lupus |
| Q70595433 | Management of systemic lupus erythematosus |
| Q40536976 | Marriage, social support, and adjustment to rheumatic disease |
| Q43885295 | Mechanical aspects of osteoarthrosis |
| Q68288354 | Mechanisms of action of methotrexate |
| Q71431828 | Mechanisms of the effects of methotrexate |
| Q72121808 | Medical management of the painful shoulder |
| Q40781031 | Methotrexate in rheumatoid arthritis |
| Q68182157 | Microbial superantigens and autoimmune disease |
| Q78813647 | Misrepresentation of treatments for arthritis |
| Q69152839 | Mixed connective tissue disease |
| Q72874219 | Muscle disease symptoms: evaluation and significance |
| Q40115421 | Musculoskeletal applications for computed tomography |
| Q73723053 | Musculoskeletal manifestations of thyroid disease |
| Q50733437 | NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE) ACCEPTED BY THE AMERICAN RHEUMATISM ASSOCIATION |
| Q40536974 | NSAID-induced gastrointestinal toxicity. |
| Q40657198 | NSAIDs in the treatment of osteoarthritis. Friends or foes? |
| Q39724872 | Network Physician Organization and Guidelines for Reviewers of Rheumatic Disease Care |
| Q35196634 | Neurobiology and inflammatory arthritis |
| Q78508127 | Neuropathic joint disease (Charcot joints) |
| Q35569769 | New developments in bacterial arthritis |
| Q41181768 | New developments in the myositis syndromes. |
| Q38678026 | New therapies for the rheumatic diseases |
| Q74475582 | Nonmedicinal therapies for osteoarthritis |
| Q53038827 | ORTHOPEDIC SURGERY IN RHEUMATOID ARTHRITIS |
| Q36186933 | Obesity and osteoarthritis of the knee |
| Q67819628 | Office-based arthroscopy |
| Q54064344 | On fibromyalgia. |
| Q67712053 | On standardization of the latex fixation test |
| Q67712057 | On standardization of the latex fixation test - reply by Dr. Jacques M. Singer |
| Q40548897 | Orthotic treatment of the hand. What's new? |
| Q73876798 | Osteoarthritis |
| Q75636224 | Osteoarthritis and its management |
| Q71745106 | Osteoarthritis of the knee--another opinion |
| Q39672910 | Osteoarthritis: a 1987 update |
| Q72367137 | Osteomyelitis |
| Q69798346 | Osteonecrosis of the hip and knee |
| Q73434912 | Osteoporosis |
| Q39570302 | Osteoporosis: diagnosis and management |
| Q33764132 | Osteoporosis: diagnosis, prevention, and treatment of established disease. |
| Q73251604 | PREGNANCY and rheumatoid arthritis |
| Q70704410 | Paget's disease of bone (osteitis deformans) |
| Q77101007 | Pain and the cervical spine |
| Q72191395 | Pain centers--whose interests do they serve? |
| Q36273264 | Pain in the lower back |
| Q69882915 | Pain perception |
| Q43497149 | Parvovirus: a review. |
| Q72612151 | Pathogenesis of osteoporosis |
| Q37043081 | Pathogenesis of the spondylarthropathies |
| Q44719722 | Pathology of ankylosing spondylitis |
| Q68856402 | Patient education in the rheumatic diseases--pros and cons |
| Q38506352 | Paul Klee and scleroderma |
| Q30537192 | Performing arts rheumatology. |
| Q78835065 | Peripheral neuropathy in rheumatoid arthritis |
| Q74039478 | Phenylbutazone (butazolidin) |
| Q73714662 | Phyenylbutazone (butazolidin) |
| Q71454625 | Physical examination of the arthritic patient |
| Q74244524 | Physical medicine in rheumatoid arthritis |
| Q77060988 | Pigmented villonodular synovitis |
| Q70810538 | Podagra is more than gout |
| Q71288365 | Polymyalgia rheumatica |
| Q34395126 | Polymyalgia rheumatica revisited. |
| Q79049874 | Polymyositis and dermatomyositis |
| Q73927994 | Prednisone and prednisolone as suppressive agents for rheumatoid arthritis |
| Q37043084 | Pregnancy and aPL |
| Q70394954 | Preliminary criteria for clinical remission in rheumatoid arthritis |
| Q71469025 | Preliminary criteria for the classification of systemic sclerosis (scleroderma) |
| Q73819412 | Present-day treatment of gout |
| Q77633501 | Preventing knee and hip osteoarthritis |
| Q40407594 | Prevention and management of glucocorticoid-induced osteoporosis. |
| Q72612155 | Prevention of osteoporosis |
| Q75984593 | Prevention of rheumatic fever |
| Q73327205 | Primary generalised osteoarthritis |
| Q71854029 | Principles of immunosuppressive therapy |
| Q78589541 | Prognosis in Still's disease |
| Q73327203 | Progressive systemic sclerosis (scleroderma) |
| Q74291833 | Proposed diagnostic criteria for rheumatoid arthritis |
| Q72874221 | Prosthetic ligaments in ACL reconstruction |
| Q70803876 | Pseudo-Lyme disease |
| Q71854027 | Psoriatic arthritis |
| Q72329251 | Psoriatic arthritis |
| Q75984597 | Psychogenic factors in rheumatoid arthritis |
| Q39842949 | Psychological aspects of arthritis |
| Q74382240 | Quantitative analysis of uric acid in blood and urine; methods and interpretation |
| Q40967386 | RHEUMATIC DISEASES IN THE USSR |
| Q73225991 | Radiographs in heel pain |
| Q66996125 | Radionuclide bone and joint imaging in rheumatology |
| Q70337703 | Raynaud phenomenon |
| Q67457455 | Reactive arthritis |
| Q78549952 | Recent modifications in serological tests for rheumatoid arthritis |
| Q36261953 | Receptor-targeted immunotherapy. |
| Q73020115 | Recognition and management of spinal cord and nerve root compression caused by osteophytes |
| Q69016387 | Reflex sympathetic dystrophy syndrome |
| Q67712026 | Rehabilitation and rheumatoid arthritis |
| Q71510302 | Reiter's syndrome |
| Q77060983 | Reiter's syndrome |
| Q43873849 | Reiter's syndrome. Evaluation of preliminary criteria for definite disease. |
| Q73954427 | Relative cortisone deficiency simulating exacerbation of arthritis |
| Q67974932 | Relevance of outcomes research to the practice of rheumatology |
| Q44778467 | Renal tubular transport of urate in man. |
| Q73020117 | Replacement of the femoral head and other arthroplastic procedures in severe osteoarthritis of the hip |
| Q41031856 | Repository benzathine penicillin for the control of rheumatic fever |
| Q69548750 | Revised criteria for the classification of rheumatoid arthritis |
| Q72279533 | Rheumatic disease |
| Q45097589 | Rheumatic diseases and inherited complement deficiencies |
| Q38648400 | Rheumatic fever in the 1980s |
| Q40710776 | Rheumatic fever: new insights into an old disease. |
| Q79316706 | Rheumatoid arthritis and agammaglobulinemia |
| Q35569778 | Rheumatoid arthritis and depression: an overview |
| Q72365816 | Rheumatoid arthritis of the cervical spine |
| Q39924794 | Rheumatoid factors in rheumatoid arthritis |
| Q75984591 | Rheumatoid spondylitis: clinical features and current methods of treatment |
| Q42057208 | Rheumatologic emergencies |
| Q41468758 | Rheumatologic manifestations of tuberculosis. |
| Q79027061 | Role of the newer uricosuric agents in management of gout |
| Q77176856 | Running and the musculoskeletal system |
| Q76733533 | SURGERY OF THE HIP IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS |
| Q76551879 | SYMPOSIUM ON INFLAMMATION AND ROLE OF FIBRIN IN THE RHEUMATIC DISEASES |
| Q76409020 | Salicylates |
| Q41468751 | Sarcoid arthropathy. |
| Q71722306 | Scleroderma: diagnosis and treatment, Circa 1995 |
| Q39705042 | Scoliosis: a review for the generalist |
| Q36679941 | Selected data on primary gout |
| Q40912953 | Selected surgical topics in rheumatoid arthritis |
| Q74149668 | Selective COX-2 inhibition |
| Q72103051 | Self recognition in the regulation of immune reactivity |
| Q34974439 | Sensible approach to low back pain. |
| Q46051414 | Serial bone mineral density studies in the evaluation and management of osteoporosis. |
| Q39695291 | Seronegative spondylarthropathies |
| Q74487265 | Serum proteins, glycoproteins and mucoproteins in the rheumatic diseases |
| Q34111165 | Sex and arthritis. |
| Q41196013 | Should minocycline be used to treat rheumatoid arthritis? |
| Q36479989 | Silicone breast implants and rheumatic disease |
| Q71175084 | Sjögren's syndrome |
| Q71979506 | Sleep and rheumatic disease |
| Q71702868 | Social security disability and the arthritis patient |
| Q74640427 | Some aspects of juvenile rheumatoid arthritis |
| Q71188945 | Spinal stenosis |
| Q34306627 | Sports, exercise, and arthritis |
| Q40029883 | Structure and function of the synovial membrane |
| Q40748464 | Surgical alternatives for adolescents with severe arthritis. |
| Q79425246 | Surgical rehabilitation of the hand and upper extremity in rheumatoid arthritis |
| Q79411325 | Synovianalysis: an aid in arthritis diagnosis |
| Q34158253 | Systemic lupus erythematosus: women's health issues. |
| Q72269359 | Systemic rheumatic disorders ("collagen disease") in childhood: lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma. I |
| Q72258568 | Systemic rheumatic disorders ("collagen disease") in childhood: lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma. II |
| Q50729489 | THE 1963 ANNUAL MEETING OF THE AMERICAN RHEUMATISM ASSOCIATION |
| Q50729839 | THE 1964 ANNUAL MEETING OF THE AMERICAN RHEUMATISM ASSOCIATION |
| Q77197561 | THE ARTICULAR MANIFESTATIONS OF INTESTINAL DISEASE |
| Q77161975 | THE ELEVENTH (1964) INTERIM SCIENTIFIC SESSION OF THE AMERICAN RHEUMATISM ASSOCIATION |
| Q76812619 | THE FUNCTIONING OF THE DIFFUSE MACROMOLECULES OF JOINTS |
| Q77197569 | THE NON-SPECIFIC MANAGEMENT OF RHEUMATOID ARTHRITIS |
| Q76815202 | THE TENTH (1963) INTERIM SCIENTIFIC SESSION OF THE AMERICAN RHEUMATISM ASSOCIATION |
| Q35458869 | THE THYMUS AND CENTRAL LYMPHOID TISSUE IN IMMUNOBIOLOGY |
| Q72551431 | The "R.A. cell", "ragocyte", or "inclusion body cell" |
| Q50582355 | The 1965 annual meeting of the American Rheumatism Association |
| Q50582391 | The 1966 annual meeting of the American Rheumatism Association. |
| Q39877821 | The 1968 interim scientific session of the American Rheumatism Association |
| Q70137803 | The 1969 Interim Meeting of the American Rheumatism Association |
| Q50582575 | The 1969 annual meeting of the American Rheumatism Association |
| Q69929110 | The 1970 annual meeting of the American Rheumatism Association |
| Q39942915 | The 1972 annual meeting of the American Rheumatism Association |
| Q50532366 | The 1976 annual meeting of the American Rheumatism Association. |
| Q50532874 | The 1978 annual meeting of the American Rheumatism Association. |
| Q66705621 | The 1979 Annual Meeting of the American Rheumatism Association |
| Q71745110 | The AHCPR practice guidelines for low back pain |
| Q67974929 | The Americans with Disabilities Act |
| Q79548517 | The Gm and Inv, and the rheumatoid factors: interrelations, interpretations and implications |
| Q74208646 | The L.E. cell test |
| Q74734063 | The Marfan syndrome |
| Q76465291 | The Ninth (1962) Interim Scientific Session of the American Rheumatism Association |
| Q74640421 | The Ninth International Congress on Rheumatic Diseases |
| Q68722332 | The Twelfth (1966) Interim Scientific Session of the American Rheumatism Association |
| Q74291837 | The agglutination reaction as a diagnostic aid in rheumatoid arthritis |
| Q73255061 | The allure of alternative therapies |
| Q78623198 | The anemia of arthritis |
| Q50727842 | The annual meeting of the American Rheumatism Association. |
| Q33367183 | The antiphospholipid antibody syndrome: new pieces to the puzzle. |
| Q41016108 | The antistreptolysin o titer in rheumatic fever; methods and significance. |
| Q40335623 | The biology of aging and the immune system. |
| Q78623196 | The blood in systemic lupus erythematosus |
| Q78372644 | The carditis and aortitis of ankylosing spondylitis |
| Q73391551 | The chronic rheumatoid cripple: rehabilitation assets and deficits |
| Q73647805 | The course of rheumatoid arthritis |
| Q40940100 | The cross-reaction of group A streptococci with heart tissue and its relation to induced autoimmunity in rheumatic fever |
| Q43799196 | The current status of methotrexate use in rheumatic diseases. |
| Q40279675 | The degradation of collagen |
| Q54155778 | The development of classification criteria for children with juvenile rheumatoid arthritis. |
| Q74322102 | The differential diagnosis of ankylosing spondylitis |
| Q78802274 | The early radiological signs of rheumatoid arthritis |
| Q39929403 | The economics of arthritis |
| Q40578771 | The effect of exercise on immune function |
| Q40654546 | The effect of pregnancy on rheumatoid arthritis |
| Q79351699 | The eighth (1961) interim scientific session of the American Rheumatism Association |
| Q46168967 | The endocrine system and connective tissue disorders |
| Q71576190 | The epidemiology of hyperuricemia |
| Q39977386 | The epidemiology of rheumatoid arthritis: a review. I. Surveys |
| Q39977365 | The epidemiology of rheumatoid arthritis: a review. II. Incidence and diagnostic criteria |
| Q41019202 | The erythrocyte sedimentation rate and the C-reactive protein tests |
| Q67496382 | The etiology of rheumatoid arthritis |
| Q77293717 | The eye and rheumatic disease |
| Q69798349 | The eye in rheumatic disease |
| Q73094534 | The fibrosits syndrome |
| Q40912960 | The future of rheumatoid arthritis treatment |
| Q75984582 | The genetic aspects of rheumatic diseases |
| Q73839882 | The genetics of ankylosing spondylitis |
| Q40525200 | The genetics of juvenile rheumatoid arthritis. |
| Q73020112 | The heart in rheumatoid arthritis |
| Q78578836 | The hydralazine syndrome |
| Q39557620 | The immunogenetics of rheumatic diseases |
| Q75984572 | The local effects of compound F (hydrocortisone) injected into joints |
| Q72032136 | The major histocompatibility complex antigens in rheumatoid arthritis and juvenile arthritis |
| Q67830224 | The management of juvenile chronic polyarthritis |
| Q75589064 | The management of rheumatoid arthritis |
| Q74039487 | The metabolic defect in gout |
| Q40957747 | The natural histories of acute rheumatic fever |
| Q79608016 | The natural history of progressive systemic sclerosis (diffuse scleroderma) |
| Q73819409 | The natural history of rheumatoid spondylitis |
| Q74244512 | The pathology teaching set of lantern slides |
| Q78809022 | The preservation and recovery of hand function in rheumatoid arthritis |
| Q69913583 | The procainamide-induced lupus syndrome |
| Q73290465 | The rationale for physical therapy in arthritis |
| Q74014192 | The relation of chemical structure to biological activity of adreno-cortical steroids |
| Q72781754 | The relationship of mycoplasma (PPLO) to Rheumatoid arthritis and related diseases: a working conference |
| Q78978262 | The relevance of delayed allergy and homograft sensitivity to autoimmune disease |
| Q40912948 | The role of exercise in the treatment of inflammatory arthritis. |
| Q71119732 | The role of orthopedic surgery in the rheumatic diseases |
| Q79399870 | The shoulder-hand syndrome |
| Q39964063 | The structure, chemistry and metabolism of articular cartilage |
| Q40748474 | The study of practice variation in managing rheumatic diseases. |
| Q69686137 | The syndromes of bursitis |
| Q75497642 | The undesirable side-effects, withdrawal symptoms and contraindications of the use of cortisone and ACTH in rheumatic diseases |
| Q75461939 | The use of cortisone and ACTH in rheumatoid arthritis |
| Q41063506 | The use of cortisone and ACTH in the treatment of rheumatic fever. |
| Q34974445 | The use of low-dose prednisone in the management of rheumatoid arthritis. |
| Q41051522 | The use of salicylate in rheumatic fever. |
| Q73459414 | The value of long-term conservative treatment in rheumatoid arthritis |
| Q78809318 | The vascular lesions associated with rheumatoid arthritis |
| Q34065142 | Theories of autoimmunity |
| Q72367140 | Total hip arthroplasty |
| Q72704263 | Total hip replacement: "cement versus cementless" resolution |
| Q45202394 | Towards a geography of rheumatoid arthritis. |
| Q70474094 | Treatment of juvenile arthritis |
| Q70394950 | Treatment of rheumatoid arthritis |
| Q40252957 | Treatment of the gout and other forms of crystal-induced arthritis |
| Q33688460 | Tumor necrosis factor inhibitors for rheumatoid arthritis. |
| Q35014023 | Two contributions to understanding of the "fibrositis" syndrome |
| Q39683972 | Update on NSAID use in rheumatic diseases. |
| Q33754006 | Update on fibromyalgia syndrome |
| Q34207148 | Update on management of scleroderma |
| Q34974433 | Update on reactive arthritis. |
| Q33865709 | Update on the treatment of Wegener's granulomatosis |
| Q36986966 | Use of TENS in arthritis management |
| Q73789021 | Use of etanercept in children |
| Q77293714 | Use of methotrexate in children |
| Q73871733 | Use of sulfasalazine in rheumatic diseases |
| Q40926990 | Vaccination in the immunocompromised person |
| Q70784975 | Vasculitis |
| Q40748471 | Viral arthritis--the great masquerader |
| Q40139088 | Viruses and systemic lupus erythematosus |
| Q40076572 | When is scleroderma not scleroderma? The differential diagnosis of progressive systemic sclerosis |
| Q77522550 | When it's not a rheumatic disease |
| Q77522547 | When should you consider vasculitis? |
| Q74460329 | Why is the ANA result positive? |
| Q74448157 | X-ray changes of diagnostic importance in the commoner types of arthritis |
| Q74382245 | [THE INTERIM meeting of the American Rheumatism Association] |
| Q73094538 | [The National Institute of Arthritis and Metabolic Diseases] |
| Q73954425 | [The clinical course of juvenile rheumatoid arthritis] |
| Q71491729 | 99m Technetium scintiphotography in arthritis. II. its nonspecificity and clinical and roentgenographic correlations in rheumatoid arthritis |
| Q44611161 | A Multi-Center Double-Blind Crossover Comparison Study of Naproxen and Aspirin in Patients with Rheumatoid Arthritis |
| Q71732992 | A Population Survey of Rheumatoid Arthritis: Epidemiological Aspects of the Syndrome, its Pattern, and Effect on Gainful Employment |
| Q54071411 | A Prospective Clinical Five Year Follow Up Study After Open Synovectomy of the Knee Joint in Patients with Chronic Inflammatory Joint Disease: The prognostic power of clinical, arthroscopic, histologic and immunohistologic variables |
| Q35110063 | A Review of Sleep in Selected Immune and Autoimmune Disorders |
| Q40731088 | A lupus antibody syndrome associated with hypernephroma |
| Q39605121 | A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus |
| Q30881149 | A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma: logistic regression of clinical and laboratory data |
| Q69528851 | Abnormal Structures in Circulating Lymphocytes from Patients with Systemic Lupus Erythematosus and Related Diseases |
| Q67473400 | Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases |
| Q68320802 | Abnormal glycosylation of serum igg from patients with chronic inflammatory diseases |
| Q40647046 | Acetylator phenotype in systemic lupus erythematosus |
| Q39194003 | Acidosis of synovial fluid correlates with synovial fluid leukocytosis |
| Q68424674 | Activated Monocytes Induce Arthritis-associated Changes in Mitochondria of Cultured Synovial Fibroblasts |
| Q69762738 | Acute Gouty Arthritis and Response to Colchicine in the Virtual Absence of Synovial-Fluid Leukocytes |
| Q41258048 | Acute myocardial infarction following gold sodium thiomalate induced vasomotor (nitritoid) reaction |
| Q72925591 | Acute temporomandibular arthritis in a patient with bruxism and calcium pyrophosphate deposition disease |
| Q66914932 | Adrenocortical carcinoma in a patient with systemic lupus erythematosus treated with azathioprine |
| Q40703118 | Alpha-1-antitrypsin phenotypes in rheumatoid arthritis and systemic lupus erythematosus |
| Q39995651 | Alterations in immunologic mechanisms in diseases of the gastrointestinal tract |
| Q41016280 | An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus |
| Q39990460 | An appraisal of chloroquine |
| Q41723862 | An evaluation of salivary scintigraphy in sögren's syndrome |
| Q69245661 | An immunofluorescent method for the detection of antigammaglobulin antibodies |
| Q40771003 | An immunofluorescent method usingcrithidia luciliae to detect antibodies to double-stranded DNA |
| Q40149947 | Analysis of dna structure by hydroxyapatite columns and ethidium bromide fluorescence techniques. a comparative study and effect on dna binding |
| Q72332754 | Ankylosing (Marie-Strümpell) Spondylitis |
| Q71800414 | Ankylosing Spondylitis and Spondylitis Accompanying Ulcerative Colitis, Regional Enteritis, Psoriasis and Reiter's Disease. A Comparative Study |
| Q39526401 | Anti-Dna Antibody Determination in Systemic Lupus Erythematosus (Sle): Predictive Value as Compared with the LE-Cell Test |
| Q37893765 | Antibiotic Treatment of Venereal Disease and Reiter's Syndrome in a Greenland Population |
| Q66887394 | Antibodies to dAT detected by membrane filtration |
| Q67348645 | Antibodies to dna in patients with rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q72669713 | Antibodies to single-stranded dna in patients with discoid lupus erythematosus |
| Q40770995 | Antibody levels to enteric bacteria in juvenile rheumatoid arthritis |
| Q66883013 | Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus |
| Q40762771 | Antiglobulins in juvenile rheumatoid arthritis |
| Q39406225 | Antinuclear antibodies (ANA): Immunologic and clinical significance |
| Q39559650 | Antithyroid-antibody activity in the snyovial fluid of patients with various arthritides |
| Q72332746 | Approaches to Deformities in Rheumatoid Arthritis |
| Q43560948 | Are gallstones less prevalent in rheumatoid arthritis |
| Q54372145 | Arthritis as the presenting feature of childhood leukemia |
| Q70311190 | Arthritis in Patients with Antimitochondrial Antibodies |
| Q68320807 | Arthritis-associated changes in flow cytometric characteristics of cultured synovial fibroblasts |
| Q41520857 | Arthroplasty Of The Knee Joint: With Special Reference To Complications |
| Q57136619 | Assessment of inflammatory joint activity in rheumatoid arthritis and changes in atmospheric conditions |
| Q67262358 | Association between HLA-BW38 and peripheral psoriatic arthritis |
| Q39111681 | Association between hla and cutaneous necrotizing venulitis |
| Q66888389 | Association of Antibodies to Ribonucleoprotein and Sm Antigens with Mixed Connective-Tissue Disease, Systemic Lupus Erythematosus and Other Rheumatic Diseases |
| Q41045161 | Association of IgG Anti-Brain Antibodies with Central Nervous System Dysfunction in Systemic Lupus Erythematosus |
| Q66880668 | Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus |
| Q40673429 | Automated rheumatoid factor assay in a population of patients with rheumatic disease |
| Q54262288 | Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study |
| Q40686448 | B-Lymphocyte Alloantigens Associated with Systemic Lupus Erythematosus |
| Q39708969 | Barrett's esophagus in scleroderma: Increased prevalence and radiographic findings |
| Q42234695 | Bladder Toxicity With Chronic Oral Cyclophosphamide Therapy in Nonmalignant Disease |
| Q66938001 | Bone Loss in Patients with Rheumatoid Arthritis |
| Q39714876 | Cardiac Alterations in Ankylosing Spondylitis |
| Q40659259 | Case Report: Fatal Gastrointestinal Hemorrhage in Mixed Connective Tissue Disease |
| Q40425439 | Chronic Fatigue Syndrome 1: Etiology and Pathogenesis |
| Q40661641 | Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis |
| Q67833068 | Class II Major Histocompatibility Complex Antigen Expression on Unstimulated and Gamma-Interferon Stimulated Monocytes from Patients with Multiple Sclerosis, Rheumatoid Arthritis and Normal Controls |
| Q68446570 | Clinical assessment of atlantoaxial instability using the sharp-purser test |
| Q39780955 | Clinical assessment of immune-complex disease in children with systemic lupus erythematosus |
| Q67348657 | Clinical experiences |
| Q70232740 | Clinical profiles of patients with antibodies to nuclear ribonucleoprotein |
| Q44895938 | Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies |
| Q70229716 | Clonally restricted anti-igg antibodies in rheumatoid arthritis |
| Q44550775 | Coexistence of ankylosing spondylitis and rheumatoid arthritis |
| Q68320844 | Common tests for rheumatoid factors: poorly standardized but ubiquitous |
| Q44063301 | Comparative studies of antilymphocyte, antipolynucleotide, and antiviral antibodies among families of patients with systemic lupus erythematosus |
| Q41400058 | Comparison Of The Presence Of Immune Complexes In Felty'S Syndrome And Rheumatoid Arthritis |
| Q39547200 | Comparison of Three Immunoassays for Immune Complexes in Rheumatoid Arthritis |
| Q67011750 | Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis |
| Q41364293 | Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus |
| Q69637806 | Conflict Between Epidemiological And Clinical Diagnosis Of Rheumatoid Arthritis In A Population Sample |
| Q41668502 | Continuing education in rheumatoid arthritis for the primary care physician |
| Q70247572 | Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's Phenomenon |
| Q72836812 | Controversy in Medicine Debate: The defect in rheumatoid arthritis is inherent to the lymphocyte |
| Q72113302 | Counter irritation test in primary fibromyalgia |
| Q66882147 | Cutaneous vessel immune deposits in rheumatoid arthritis |
| Q51648793 | Cyclic Nucleotides and Catecholamines in Rheumatoid Arthritis |
| Q40234267 | Cyclic Nucleotides in Joint Fluid in Rheumatoid Arthritis and in Reiter's Syndrome |
| Q40886801 | Decreased Lymphocyte Response To Pha, Con-A, And Calcium Ionophore (A23187) In Patients With Ra And Sle, And Reversal With Levamisole In Rheumatoid Arthritis |
| Q40647057 | Decreased lymphocyte reactivity to a suboptimal concentration of phytohemagglutinin in sjögren's syndrome |
| Q67442599 | Deforming arthritis of the hands in polymyositis |
| Q39523058 | Demonstration of β1h globulin together with c3 in the dermal-epidermal junction of patients with systemic lupus erythematosus |
| Q39536959 | Deposition of β1h globulin in kidneys of patients with immune renal disease |
| Q41056078 | Deposits Of Immunoglobulins And Complement In Skin Of Patients With Rheumatoid Arthritis: Influence Of Anti-Rheumatic Treatment |
| Q40659246 | Depressed in Vitro B—Lymphocyte Differentiation in Systemic Lupus Erythematosus |
| Q66897671 | Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus |
| Q44553313 | Dermatoglyphic study of systemic lupus erythematosus |
| Q39935258 | Diagnostic Process and Rheumatic Diseases |
| Q72808850 | Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases |
| Q41938502 | Diplopia and loss of accommodation due to chloroquine |
| Q44071475 | Direct evidence for circulating dna/anti-dna complexes in systemic lupus erythematosus |
| Q41668516 | Disappearing lumbar hyperostosis in a patient with forestier's disease: An ominous sign |
| Q40158596 | Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis? |
| Q68458747 | Down-regulation of immunoglobulin and IgM-rheumatoid factor synthesis by oral treatment of rheumatoid arthritis patients with a nonsteroidal antiinflammatory drug |
| Q41668489 | Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus |
| Q35553379 | Early rheumatoid arthritis: Toward tailor-made therapy |
| Q67442603 | Effect of aspirin on liver tests in patients with ra or sle and in normal volunteers |
| Q67753616 | Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis |
| Q66895164 | Effect of ibuprofen dosage on patient response in rheumatoid arthritis |
| Q28317793 | Effect of the Common Bile Acids on the Fibrin/Fibrinogen Fragments in Rheumatoid Synovial Fluid: A Possible Clue to the Ameliorating Effect of Jaundice in Rheumatoid Arthritis |
| Q39783918 | Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine |
| Q70224799 | Elevation of von willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis |
| Q41480714 | Epidemiology of ankylosing spondylitis in rochester, minnesota, 1935–1973 |
| Q43764674 | Evaluation of arthritis in Reiter's disease by bone scintigraphy and radiography |
| Q69219605 | Exacerbation of Systemic Lupus Erythematosus after Withdrawal of Azathioprine Therapy |
| Q44487593 | Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis |
| Q45803958 | Failure to detect type-c virus p30-related antigen in systemic lupus erythematosus: false-positive reaction due to protease activity |
| Q40721784 | Familial Abnormalities of Suppressor-Cell Function in Systemic Lupus Erythematosus |
| Q71055137 | Familial Systemic Lupus Erythematosus and C4Deficiency |
| Q57731172 | Female hormones reduce neutrophil responsiveness in vitro |
| Q39702231 | Fetal mortality and malformations associated with experimental infections of Western equine encephalomyelitis vaccine virus in Rhesus monkeys (Macaca mulatta) |
| Q70249514 | Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid |
| Q41077261 | Fibrinogen catabolism in systemic lupus erythematosus |
| Q72735392 | Fibronectin on the surface of articular cartilage in rheumatoid arthritis |
| Q48913186 | Fibrositis (Fibromyalgia Syndrome) and the Dental Clinician |
| Q39886999 | Frequency of systemic lupus erythematosus in different ethnic groups in hawaii |
| Q39316868 | Gamma globulin complexes in rheumatoid pericardial fluid |
| Q69367112 | Gastrointestinal Protein Loss in Rheumatoid Arthritis, Studied with51cr-Chromic Chloride and125i Albumin |
| Q40689831 | Gastrointestinal systemic sclerosis in serologic mixed connective tissue disease |
| Q40721778 | Genetic Differences between Primary and Secondary Sicca Syndrome |
| Q54105690 | Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis |
| Q71630286 | Gold nephropathy a clinical and pathologic study |
| Q67903497 | Greater Trochanteric Pain Syndrome (Trochanteric Bursitis) in Low Back Pain |
| Q67328903 | HL-A W27 and Juvenile Rheumatoid Arthritis |
| Q53791486 | HL-A-W27 — A Useful Discriminator in the Arthropathies of Inflammatory Bowel Disease |
| Q40682068 | HLA-D and IA antigens in rheumatoid arthritis and systemic lupus erythematosus |
| Q70352069 | HLA—-DR4 is not a requisite for autoimmunity to collagen in rheumatoid arthritis |
| Q70228049 | HLA—DR4 and rheumatoid arthritis in Mexican mestizos |
| Q39212506 | Hand structure and function in an industrial setting |
| Q47589784 | Heart rate variability in patients with rheumatoid arthritis |
| Q48012715 | High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis |
| Q41438862 | Hla-b27 in mexican patients with ankylosing spondylitis |
| Q72795904 | How Does Bechterew's Syndrome (Ankylosing Spondylitis) Start?: Interrelations between Onset of Symptoms |
| Q40138717 | Hyporesponsiveness of lymphocytes to virus antigens in rheumatoid arthritis |
| Q40941787 | Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue diseases |
| Q44500913 | IgG antilymphocyte antibodies in SLE detected by125I protein A |
| Q41643954 | Immune Interferon in the Circulation of Patients with Autoimmune Disease |
| Q39814444 | Immune complexes and complement catabolism in ankylosing spondylitis |
| Q72669716 | Immunoelectron microscopic demonstration of prostaglandin e in rheumatoid synovium |
| Q39451383 | Immunoglobulin Deposits in the Dermo-Epidermal Junction Zone in Patients with Systemic Lupus Erythematosus, Rheumatoid Arthritis and Temporal Arteritis Compared by Serological Testing Including α2-Macroglobulin |
| Q67250338 | Immunoglobulin inclusions in rheumatoid arthritis polymorphonuclear cells: Lack of correlation with circulating immune complexes |
| Q40771000 | Immunohistochemical localization of prostaglandin e in rheumatoid synovial tissues |
| Q70232744 | Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives |
| Q72693875 | Immunoreactive Alpha2-Macroglobulin in Rheumatoid Synovial Membrane |
| Q72704685 | Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by125i-radioimmunoassay |
| Q69733299 | Incidence of infection in systemic lupus erythematosus |
| Q67242449 | Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and felty's syndrome sera |
| Q39649336 | Increased excretion of two sialic acid-containing trisaccharides in the urine of patients with rheumatoid arthritis |
| Q40652709 | Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium |
| Q72826279 | Inhibition of Immune Precipitation in Rheumatic Disease:A Clinical and laboratory Study |
| Q68336594 | Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients |
| Q67442587 | Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis |
| Q45888457 | Intraarticular methylprednisolone therapy in hemophilic arthropathy |
| Q47929666 | Is Nørgaard's Radiological Sign for Early Rheumatoid Arthritis Reliable?: An Epidemological Approach |
| Q43675800 | Juvenile rheumatoid arthritis: Clinical characteristics in 100 Thai patients |
| Q68470726 | Juxtaarticular bone loss in experimental inflammatory arthritis |
| Q72606976 | Laboratory investigation of systemic lupus erythematosus |
| Q70183427 | Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis |
| Q40659240 | Limited Anti-DNA Antibody Specificity in Systemic Lupus Erythematosus |
| Q39273361 | Limited plasmapheresis in rheumatoid arthritis with vasculitis |
| Q66912444 | Long-term maintenance therapy with azathioprine in systemic lupus erythematosus |
| Q66887395 | Lymphocyte response to mitogens in progressive systemic sclerosis |
| Q40031143 | Lymphocyte response to virus antigens in systemic lupus erythematosus |
| Q66882156 | Lymphocyte responsiveness in systemic lupus erythematosus |
| Q40770991 | Lymphocytes eluted from synovial tissue of juvenile rheumatoid arthritis patients |
| Q66886803 | Lymphocytotoxic antibodies in sle patients and their relatives |
| Q66887392 | Lymphocytotoxic antibody activity in cryoprecipitates from serum of patients with SLE |
| Q43927539 | Malignancy in a series of 70 patients with systemic lupus erythematosus |
| Q37809701 | Management of psoriatic arthritis |
| Q41723894 | Management of rheumatoid arthritis with oral gold |
| Q39922596 | Medical Management of Primary Hypertension |
| Q66890223 | Medical Management of Renal Scleroderma |
| Q66963825 | Methotrexate and prednisolone treatment of a child with psoriatic arthritis |
| Q43983874 | Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight–week randomized, double-blind trial |
| Q46847911 | Migrainous phenomena in systemic lupus erythematosus |
| Q44397065 | Monoclonal antibody 6b6.6 defines a cross-reactive kappa light chain idiotope on human monoclonal and polyclonal rheumatoid factors |
| Q41668485 | Mortality in lupus nephritis |
| Q72695417 | Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus — nerve biopsy and response to plasma exchange |
| Q43587842 | Multiple myeloma complicating the course of seronegative systemic lupus erythematosus |
| Q46575826 | Muscle disease in progressive systemic sclerosis. diagnostic and therapeutic considerations |
| Q72636316 | Musculoskeletal Complaints in the Elderly |
| Q44302347 | Need, Demand, and Supply of Medical Care in a Population Sample of Rheumatoid Arthritis |
| Q40172641 | Occupational musculoskeletal stress and disorders of the neck and shoulder: a review of possible pathophysiology |
| Q46822371 | Occurrence of Amyloid in the Teeth-Supporting Tissues of Patients with Rheumatoid Disease:An Immunohistochemical Study |
| Q67337023 | On survivorship in the nephritis of systemic lupus erythematosus |
| Q72742462 | On the heterogeneity of osteoarthritis |
| Q44446036 | Oral mucosal ulceration in systemic lupus erythematosus |
| Q47949078 | Orthopaedic Infections In Patients With Rheumatoid Arthritis |
| Q70388084 | Osteoarticular changes in Wilson's disease |
| Q71630280 | Oxygen tension in synovial fluids |
| Q71110617 | Pathogenetic Mechanisms of Rheumatic Disorders |
| Q66940528 | Pathogenic implications of age of onset in juvenile rheumatoid arthritis |
| Q69591361 | Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy |
| Q44979438 | Perforation of nasal septum in rheumatic diseases |
| Q72732468 | Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus |
| Q43211310 | Pets and rheumatoid arthritis an epidemiologic survey |
| Q41790326 | Pharmacology of allopurinol |
| Q40262877 | Plasma And Synovial Fluid cAMP In Patients With Rheumatoid Arthritis |
| Q67064319 | Platelet Count and Disease Activity in Juvenile Rheumatoid Arthritis |
| Q71055128 | Platelet Kinetics in Systemic Lupus Erythematosus (SLE), with Special Reference to Corticosteroid and Azathioprine Therapy |
| Q40717619 | Platelet aggregation and aggregation inhibition by different antiglobulins and antiglobulin complexes from sera of patients with rheumatoid arthritis |
| Q72773015 | Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: A platelet specific immunoglobulin inducing the release reaction |
| Q41056095 | Predominance Of Cells With T-Markers In The Lymphocytic Infiltrates Of Synovial Tissue In Psoriatic Arthritis |
| Q39889591 | Primary amyloidosis resembling sicca syndrome |
| Q66888393 | Problems in Differentiating SLE and Mixed Connective-Tissue Disease |
| Q53928792 | Prognostic Implications of Cutaneous Immunoglobulin Deposits In Systemic Lupus Erythematosus |
| Q33286668 | Prognostic factors in systemic lupus erythematosus |
| Q40000480 | Pseudogout: Clinical observations and chemical analyses of deposits |
| Q67315514 | Psychosocial factors in juvenile rheumatoid arthritis |
| Q67315516 | Quantitative sacroiliac scintigraphy in patients with crohn' disease |
| Q72817219 | Rapidly progressive aortic incompetence in juvenile ankylosing spondylitis: a case report |
| Q66961003 | Re-Examination of Histocompatibility Antigens Found in Patients with Juvenile Rheumatoid Arthritis |
| Q69385208 | Reankylosis of the hip joint in ankylosing spondylitis after total hip replacement |
| Q40720281 | Reassessment of the clinical significance of native dna antibodies in systemic lupus erythematosus |
| Q33987313 | Recent observations on central nervous system lupus erythematosus |
| Q67437557 | Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus |
| Q67009780 | Reiter's Syndrome Re-Evaluated |
| Q40220238 | Relationship Between Life Stress Factors And Viral Antibody Levels In Patients With Juvenile Rheumatoid Arthritis |
| Q67324729 | Relationship of Hla-Dw3 and Hla-B8 to Sjögren'S Syndrome |
| Q72675625 | Reproducibility studies for anti-DNA antibody detection in systemic lupus erythematosus and related diseases. Fiax fluorometric immunoassay and farr radioimmunoassay |
| Q69383440 | Response of Rheumatoid Arthritis with Leukopenia to Gold Salts |
| Q66979105 | Reversible proteinuria as a complication of oral gold therapy |
| Q69158750 | Rheumatic disease sera reactive with capillaries in the mouse kidney |
| Q39397757 | Rheumatic disorders associated with diabetes mellitus: Literature review |
| Q70321415 | Rheumatoid chyliform bursitis: pathogenetic role of rheumatoid nodules |
| Q44528731 | Roentgenographic prevalence of chondrocalcinosis |
| Q39557429 | Search for epstein-barr and type c oncornaviruses in systemic lupus erythematosus |
| Q40202549 | Search for type-c oncornavirus–related genetic information in tissues from patients with systemic lupus erythematosus |
| Q69355642 | Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosu guidelines for dosage |
| Q70324545 | Sequential appearance of fibronectin and collagen fibres in experimental arthritis in rabbits |
| Q40675927 | Serologic Studies In Patients With Systemic Lupus Erythematosus And Central Nervous System Dysfunction |
| Q72696406 | Serum ?2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus |
| Q70489970 | Serum Urate in Healthy Men — Intermittent Elevations and Seasonal Effect |
| Q69373633 | Serum anti-immunoglobulins in psoriatic arthritis as compared with rheumatoid arthritis |
| Q40720274 | Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus |
| Q72664589 | Serum interferon levels in patients with systemic lupus erythematosus |
| Q49178404 | Severe autoimmune anemia and thrombopenia in mixed connective tissue disease |
| Q67262301 | Shoulder swelling in rheumatoid arthritis secondary to subacromial bursitis |
| Q39638467 | Significance of serum c-reactive protein elevation in patients with systemic lupus erythematosus |
| Q72749846 | Sjöugren's syndrome influence of multiple hla-d region alloantigens on clinical and serologic expression |
| Q34543254 | Solubility enhancement of cox-2 inhibitors using various solvent systems |
| Q72884888 | Some New Aspects of the Pharmacotherapy of Rheumatoid Arthritis |
| Q72102755 | Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sj�gren's syndrome |
| Q43661580 | Spinal pseudarthrosis with paraplegia in ankylosing spondylitis |
| Q67324727 | Studies Of The Effects Of Pregnancy Serum On Polymorphonuclear Leukocyte Functions |
| Q47761043 | Studies of isolated synovial lining cells of rheumatoid and nonrheumatoid synovial membranes |
| Q72557661 | Sulphasalazine-induced systemic lupus erythematosus in a child |
| Q39740396 | Surface characteristics of synovial fluid and peripheral blood lymphocytes in inflammatory arthritis |
| Q71439618 | Survivorship and Death in Rheumatoid Arthritis |
| Q71630283 | Synovial fluid findings in systemic lupus erythematosus (SLE) |
| Q71809685 | Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases |
| Q41668454 | Synovial permeability in rheumatoid arthritis |
| Q72745147 | Synthesis of electrophoretically restricted IgG by cultured rheumatoid synovium |
| Q39547208 | Systemic Lupus Erythematosus and Amyloidosis |
| Q41022401 | Systemic Lupus Erythematosus—A Zoonosis? |
| Q72011190 | Systemic lupus erythematosus and anticardiolipin antibodies in Klinefelter's syndrome |
| Q24806565 | T cell integrin overexpression as a model of murine autoimmunity |
| Q69959475 | Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study |
| Q47995898 | The Arthropathy of Hemochromatosis Without Hemochromatosis |
| Q51660833 | The Effect of Fasting on Plasma Cyclic Adenosine-3′, 5′-Monophosphate in Rheumatoid Arthritis |
| Q39551969 | The Extra-Articular Deposition Of Fibrinogen Antigenic Material In Patients With Rheumatoid Arthritis |
| Q47981964 | The Fourth Component of Complement in the Cerebrospinal Fluid in Systemic Lupus Erythematosus |
| Q67689729 | The Leukocyte Protein L1 in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Osteoarthritis |
| Q70237799 | The Long-Term Clinical Course of Systemic Lupus Erythematosus in End-Stage Renal Disease |
| Q39830853 | The Primary Plasmin Inhibitor in Rheumatoid Synovial Fluid |
| Q70286031 | The Relationship of Renal Histopathological Lesions to Immunoglobulin Classes and Complement Fixation of Anti-Native DNA Antibodies in Systemic Lupus Erythematosus |
| Q44829626 | The Rheumatic Diseases in Childhood |
| Q34216353 | The Shoulder-Pad Sign — A Diagnostic Feature of Amyloid Arthropathy |
| Q72705411 | The acute phase response and its relation to amyloid A degrading activity in serum of patients with rheumatoid arthritis undergoing arthroplasty |
| Q27860872 | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis |
| Q69100665 | The arthritis of leukemia |
| Q69139515 | The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease) |
| Q41723868 | The clinical significance of raynaud's phenomenon in systemic lupus erythematosus |
| Q38583585 | The effects of a partially purified fraction of an ant venom in rheumatoid arthritis |
| Q67026483 | The growth kinetics of synovial fibroblastic cells from inflammatory and noninflammatory arthropathies |
| Q68320811 | The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis |
| Q69144481 | The macrophage-lymphocyte rosette. Its increased incidence among cells from rheumatoid synovial fluid |
| Q66965847 | The modifying effect of autologous serum on leukocyte migration inhibition by liver antigens in systemic lupus erythematosus |
| Q39414014 | The pathogenesis of amyloid deposition: A new hypothesis |
| Q41481619 | The ribonucleic acid (RNA) skin test in systemic lupus erythematosus and other connective tissue diseases |
| Q39828706 | The role of HLA B27 in the diagnosis and management of low-back pain and sciatica |
| Q67301649 | The safety of administration of penicillamine to penicillin-sensitive individuals |
| Q93804423 | The significance of lysozyme (muramidase) in rheumatoid arthritis. i. levels in serum and synovial fluid |
| Q67741457 | Timing of Pregnancy in Relation to the Onset of Rheumatoid Arthritis |
| Q28260645 | Tolmetin Sodium, a New Anti-Arthritis Drug: Double-Blind and Long-Term Studies |
| Q70223144 | Towards rationalisation of health-care delivery to rheumatic sufferers |
| Q54436826 | Treatment of psoriatic arthritis with 6-mercaptopurine |
| Q70550374 | Treatment with colchicine if the periarticular inflammation associated with sarcoidosis: a need for continued appraisal |
| Q69326908 | Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease |
| Q70228045 | Use of the HEp-2 cell substrate in the detection of antinuclear antibodies in juvenile rheumatoid arthritis |
| Q39960981 | Wrist arthropathy in calcium pyrophosphate dihydrate deposition disease |
| Q40918679 | differential diagnosis of arthritis |
Search more.